Related Experiment Videos
Cognitive-behavioral therapy for schizophrenia: a review.
Douglas Turkington1, Robert Dudley, Debbie M Warman
1Depatment of Psychiatry, Royal Victoria Infirmary, Newcastle-Upon-Tyne, United Kingdom.
Journal of Psychiatric Practice
|September 1, 2004
Summary
Cognitive-behavioral therapy (CBT) effectively manages residual schizophrenia symptoms alongside medication. This therapy shows strong, durable results for positive symptoms and depression, improving patient coping and adherence.
Area of Science:
- Psychiatry
- Clinical Psychology
Background:
- Chronic schizophrenia presents residual symptoms impacting quality of life.
- Antipsychotic medication and social skills training are standard treatments.
Purpose of the Study:
- To evaluate the efficacy of Cognitive-behavioral therapy (CBT) as an adjunctive treatment for chronic schizophrenia.
- To assess CBT's impact on residual symptoms, patient coping, and treatment adherence.
Main Methods:
- CBT techniques including trust-building, normalizing, coping enhancement, reality testing, and addressing symptom-related reactions.
- Integration of CBT with antipsychotic medication, social skills training, family therapy, and assertive community treatment.
Main Results:
- CBT demonstrated a strong effect size in managing positive symptoms, depression, and overall symptom severity.
- Positive outcomes were durable at short-term follow-up.
- CBT improved patient adherence and symptom management, enhancing coping skills.
Conclusions:
- Cognitive-behavioral therapy is a safe and effective adjunctive treatment for chronic schizophrenia.
- CBT can be delivered by supervised community psychiatric nurses and integrated with other therapeutic programs.
- Combined treatment approaches, including CBT with low-dose cognitive-enhancing antipsychotics, may yield enhanced patient responses.